Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

Haridwar/New Delhi, Jun 23 () Yoga guru <keyword id="6369109" type="PERSON" weightage="20" keywordseo="ramdev">Ramdev</keyword>'s Patanjali on Tuesday launched what he claimed was the first ayurvedic medicine to cure coronavirus disease even as the scientific community the world over struggles to develop an effective cure for the highly contagious disease. Patanjali claimed 'Coronil' and 'Swasari' had shown 100 per cent favourable results during clinical trials on affected patients, at Patanjali Yogpeeth in Haridwar. Launching the medicines at a press conference in Haridwar, Ramdev claimed "100 per cent recovery rate in 7 days". The Corona kit will be made available at Rs 545, said Acharya Balkrishna, the MD of Patanjali Ayurved. The corona kit will have medicines for 30 days. Patanjali claims that its corona medicine kit can also be taken as prevention for coronavirus. This is not an immunity booster but a coronavirus cure, Ramdev said. Manufactured by Haridwar-based Divya Pharmacy and Patanjali Ayurved Ltd, the medicine is the result of a research partnership between Patanjali Research Institute and the Jaipur based National Institute of Medical Sciences. The drug was clinically tried on 280 COVID-19 positive persons out of which 69 per cent were cured within three days, Ramdev said at the launch of the medicine held at Patanjali Yogpeeth in the presence of NIMS Director Dr Balbir Singh Tomar and allopathic and ayurvedic experts involved in the research behind making the drug. "100 per cent recovery from COVID-19 within seven days of consuming the medicine is guaranteed," Ramdev said. Coronil is made of the extracts of pure Giloy, Tulsi and Ashwagandha. A corona kit consisting of the three medicines - Coronil, Shwasari and Anu Tel. The other two medicines to be taken along with Coronil are 'Shwasari' which works on strengthening the respiratory system and cures the obvious symptoms of corona including cough, cold and fever and a nasal drop named 'Anu Tel' which helps build immunity, the firm said. Ramdev said the medicines can be ordered online through a mobile app from next Monday.

Ramdev's Patanjali launched COVID-19 medicine, 100% recovery in 7 days

(Eds: Updates with Ayush Ministry statement) Haridwar/New Delhi, Jun 23 () Yoga guru Ramdev's herbal medicine company Patanjali Ayurved on Tuesday claimed to have discovered a medicine that could cure coronavirus in just seven days - a claim that the Ayush Ministry scoffed at by seeking stopping of advertisements for the drug. While Ramdev claimed that Ayurved-based 'Coronil and Swasari' medicine have shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system, the Ayush Ministry sought from the company detailed report on composition, testing and other data of the drugs. The ministry also used powers under a 1954 law to ask the firm to "stop advertising/publicizing" claims of corona cure drug until the issue is examined by it. A government notification bars companies from advertising a cure without government approval. But it wasn't immediately clear if the drug can still be sold. Talking to , Ramdev said the medicines have been developed by Patanjali Research Center, Haridwar and privately-owned National Institute of Medical Science, Jaipur following all protocols with clinically controlled trial-based evidence. "Patanjali first conducted clinical case study and conducted clinical control trials following all protocols of drug discovery," he said. Sidestepping questions on the drug being approved by government agencies such as ICMR, Ramdev said clinical controlled study of these medicines was done in several cities including Delhi, Ahmedabad and Meerut and the RCT (Randomized Clinical Trial) controlled with placebo was conducted at Jaipur-based National Institute of Medical Sciences &amp; Research. "This was done after getting approval from Clinical Trial Registry of India (CTRI) and all other required formalities," he said. "We have followed all the parameters set up by modern science for such clinical trials." Reacting to the announcement, the Ministry of Ayush issued a statement saying, "Facts of the claim and details of the stated scientific study are not known" to it. "Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined," the ministry statement said. The ministry also asked the concerned State Licensing Authority of Uttarakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19. Under the ministry's guidelines for drug development of ayurvedic formulations, state licensing authority grants licenses for manufacturing any Ayurvedic, Siddha or Unani medicine. Ramdev at a launch press conference in Haridwar, where his company is based, claimed that his ayurvedic drugs have shown 100 per cent favourable results during the clinical trial. "We conducted a clinical case study and clinical controlled trial, and found 69 per cent patients recovered in 3 days and 100 patients recovered in 7 days," he said. According to him, this medicine is useful for prevention from COVID-19 and also for treatment. Claiming that during the trial other complications of patients were also cured and their critical parameters were normalised, he said no infected patient lost his life during the trial. Patanjali, he said, had started to work on corona medicines in December 2019. The Corona kit, priced at Rs 545, would be available pan India within a week. The kit will have medicines for 30 days. Ramdev said the medicines can be ordered online through a mobile app from next Monday. The COVID-19 therapy suggested by Patanjali is applicable for adults ranging between 15-80 years of age whereas children are advised to take half the dosage prescribed for adults. Patanjali's anti-COVID tablet, Divya Coronil Tablet consists of Giloy, Tulsi and Ashwagandha and is prescribed to be taken thrice a day with hot water 30 minutes after breakfast, lunch and dinner. Medical experts, however, were not convinced by the claims. Dr Ravi Shekhar Jha, Head of the department and senior consultant, Pulmonology, Fortis Escorts Hospital, Faridabad, said physiologically it is quite impossible that there is any medicine which can finish the viral load from the body in 5-7 days. "These claims can be very harmful because people, instead of taking actual medical help, may start rushing to these kinds of claims which have no proven clinical trial," he told . Instead of taking actual medical help, opting for a "desi nuskha" kind of a thing is just going to result in loss of precious time in curing the disease, Jha said. Noted city-based lung surgeon Dr Arvind Kumar said only a proper clinical trial can prove the efficacy of the medicine. Haridwar-based Patanjali group has an estimated turnover of around Rs 10,500 crore. It had acquired debt-ridden Ruchi Soya in a corporate insolvency resolution process for around Rs 4,350 crore after competing with Adani Group. The group is also known for venturing in uncharted areas as it had in August 2018 launched a messaging app 'Kimbho', which could not take off and is now defunct. ALM KRH ANZ MR

Ramdev's Patanjali claims to have COVID-19 medicine; Ayush Ministry frowns

<ul><li><keyword id="6356684" type="UNKNOWN" weightage="20" keywordseo="patanjali">Patanjali</keyword> chairman Archarya Balkrishna’s estimated net worth was cut down by a third in 2020.</li><li>He now ranks 919th on the <keyword id="424923" type="PERSON" weightage="20" keywordseo="Hurun-rich-list">Hurun Rich List</keyword> after having slipped 489 places.</li><li>The dip in his wealth comes at a time when he is desperately trying to launch <keyword id="9448306" type="UNKNOWN" weightage="20" keywordseo="Coronil">Coronil</keyword>, a medicine he claims is a cure for COVID-19 — a claim, which many dispute. </li></ul>Archarya Balkrishna, the chairman and CEO of Patanjali as well as the right-hand man to yoga guru <keyword id="6355107" type="UNKNOWN" weightage="20" keywordseo="Baba-Ramdev">Baba Ramdev</keyword>, took a massive hit to his wealth during the pandemic. <div type="image" title="5746a6c1b0aa6d17dd0b8657c3e31a3c_edited" msid="81294979" hostid="261" caption="&amp;lt;p&amp;gt;Acharya Balkrishna doing yoga with Baba Ramdev on Yoga Day in 2018 with two lakh people to create a world record for the largest amount of people performing yoga in one place&amp;lt;/p&amp;gt;"></div> According to Hurun’s Rich List 2021, Balkrishna’s estimated net worth dipped by 32% — more than any other Indian billionaire on the list this year in percentage terms. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Balkrishna’s estimated net worth in 2020 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Balkrishna’s estimated net worth in 2021 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">$5.3 billion </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">$3.6 billion </td></tr></tbody></table> <div type="Article" hostid="261" msid="81288884" title="Meet Jay Chaudhry, the man who studied under a tree in Himachal to become one of the world’s top billionaires today" mstype="2" mssubtype="0"></div> Balkrishna has often stated that the underlying vision for Patanjali is to replace all foreign imports with ‘swadeshi’ (locally made) products. It is one of the reasons why the massive FMCG company has its fingers dipped in nearly every business from food to clothing to power to private security. It even has projects going in the <a href="https://theprint.in/tech/how-ramdevs-patanjali-ayurved-made-a-secret-tech-entry-with-its-own-it-start-up/369203/">cloud services and IT solutions space.</a> <div type="image" title="balkrishna2_edited" msid="81295070" hostid="261" caption="&amp;lt;p&amp;gt;Acharya Balkrishna announcing the availability of Patanjali products across major online portals on 16 January 2018&amp;lt;/p&amp;gt;"></div> But luck was not on Patanjali’s side when the company decided to launch Coronil, its self-proclaimed cure for COVID-19. The claim has been disputed by many in the medical community including the World Health Organisation (WHO) and the Indian Medical Association (IMA). The state of Maharashtra has banned the sale of Coronil until it receives certification from the Ayush Ministry, which looks after all things ayurved, naturopathy, homeopathy, unani, siddha and yoga. For Balkrishna, this is not the first time that he has been caught on the wrong side of things. Balkrishna’s multi-billion dollar empire is not without its controversies Back in 2011, the Central Bureau of Investigation (CBI) filed a case of forgery and cheating against Balkrishna. <a href="https://www.businessinsider.in/small-business/people/fake-degrees-and-passports-here-is-the-real-story-of-acharya-balakrishna-ramdevs-close-aide-and-patanjali-ceo/slidelist/54365692.cms">According to the CBI</a>, the degree that Balkrishna got from the Sampurnanand Sanskrit Vishwavidyalaya in Varanasi was fake. And, it was on the basis of this fake degree that Balkrishna had procured his passport. The administration of the university also <a href="https://www.business-standard.com/article/beyond-business/the-rise-and-fall-of-balkrishna-111073000065_1.html">claimed</a> that they had no record of ever giving Balkrishna a degree. However, the case was closed two years later due to lack of evidence. In 2012, the Enforcement Directorate (ED) also filed a case against Balkrishna over money laundering charges. These were dropped after the National Democratic Alliance (NDA) came into power in 2014. <div type="image" title="6738550d3499f71f5dbe014dfcd955bd_edited" msid="81295019" hostid="261" caption="&amp;lt;p&amp;gt;Acharya Balkrishna (L), Rashtriya Swayamsevak Sangh (RSS) chief Mohan Bhagwat (C), and Baba Ramdev (R) in conversation during an RSS program in Haridwar in 2014&amp;lt;/p&amp;gt;"></div> Balkrishna holds 94% stake in Patanjali but he does not take home a salary, according to the <a href="https://economictimes.indiatimes.com/news/company/corporate-trends/how-acharya-balkrishna-built-a-multi-crore-company/built-for-success/slideshow/60853399.cms">Economic Times</a>. He claims to work 15 hours a day, regardless of whether it is a Sunday or any other holiday. According to financial data accessed by business intelligence firm <a href="https://www.business-standard.com/article/companies/patanjali-ayurved-s-revenue-and-profit-rise-but-still-far-from-glory-days-120111301248_1.html">Tofler</a>, Patanjali reported a net profit of ₹423 crore for FY20. But, even with that positive growth, Patanjali is far from its glory days of yore where its revenue used to double year-on-year. The company has been facing issues since the goods and services tax (GST) was introduced in 2017, disrupting its operations. Patanjali also <a href="https://www.livemint.com/companies/news/patanjali-ayurved-completes-acquisition-of-bankrupt-ruchi-soya-for-rs-4-350-crore-11576684912487.html">acquired Ruchi Soya in 2019</a>, which placed further burden on its financials. SEE ALSO: <a href="https://www.businessinsider.in/thelife/personalities/news/ritesh-agarwal-kishore-biyani-and-acharya-balkrishna-net-worth-went-down-in-year-2020-as-per-hurun-list/slidelist/81293374.cms">OYO’s Ritesh Agarwal and Future Group’s Kishore Biyani did not make the cut this year to be among India’s richest billionaires</a> <a href="https://www.businessinsider.in/thelife/personalities/news/gautam-adani-naveen-jindal-anand-mahindra-and-kumar-mangalam-birla-increased-their-net-worth-in-2020/slidelist/81290572.cms">Gautam Adani, Naveen Jindal, Anand Mahindra and Kumar Mangalam Birla increased their net worth despite COVID-19 wreaking havoc</a> <a href="https://www.businessinsider.in/tech/news/top-10-tech-billionaires-in-india-as-per-hurun-rich-list-2021/slidelist/81287575.cms">Top 10 tech billionaires in India — Shiv Nadar saw his net worth increase by $10 billion</a>

Patanjali’s Acharya Balkrishna is the biggest loser on Hurun’s Rich List of Indian billionaires

New Delhi, Nov 19 () Baba Ramdev-led Patanjali Ayurved on Tuesday said it has achieved a revenue of Rs 3,562 crore in April-September 2019-20, the highest ever in the first half of any financial year.
The Haridwar-based firm has reported a revenue of Rs 1,793 crore in April-June and Rs 1,769 crore in July-September in the ongoing fiscal, a company official said. 
"This is the figure of the Patanjali Ayurved and does not indicate of all business. We have done internal reconstruction and some of the product lines, which were earlier handled by the company have been assigned to different companies," he said.
 The company had reported a revenue of Rs 937 crore and Rs 1,576 crore in June quarter and September quarter of 2018-19, respectively. 
"The most remarkable and noticeable thing is that Patanjali Ayurved has made a comeback. It has achieved the highest ever H1 figure in its history," Patanjali spokesperson S K Tijarawala told .
However, the company did not share the net profit figure.
"In 2018-19, Patanjali Ayurved had alone reported a revenue of Rs 8,329 crore," he said, adding that the group's turnover was much higher than this figure.
On the outlook for the second half of 2019-20, Tijarawala said: "It would be almost double of what we have in H1."
During the last fiscal, he said the company achieved a revenue of Rs 2,388 crore in the third quarter and Rs 3,698 crore in the last quarter.
Patanjali has consolidated and strengthened the supply chain, he said, adding that the group has come out from the negative impact of GST and demonetisation.
"It took us some time to align with the GST system," he added.
Patanjali Ayurved is mainly into FMCG business and its Ayurvedic medicines.
The company's biscuit, noodles, dairy businesses as well as solar panel and apparel businesses are not part of Patanjali Ayurved. KRH ANU

Patanjali Ayurved posts Rs 3,562 cr revenue for Apr-Sep

<ul><li>A viral video shows Dr <keyword id="4112857" type="PERSON" weightage="20" keywordseo="Parmeshwar-Arora">Parmeshwar Arora</keyword> standing through the skyroof of his Audi going around the streets of Gurugram sharing home remedies to fight the <keyword id="1754604" type="PERSON" weightage="20" keywordseo="coronavirus">coronavirus</keyword>.</li><li>The remedies shared by the renowned Ayurvedic doctor are proven ways to boost immunity, he went a step too far by saying it will kill the virus.</li><li>Ayurveda – the field of alternative medicine has gained immense popularity in the wake of COVID-19.</li></ul>Every morning, Dr Parmeshwar Arora, standing through the skyroof of his Audi and speaking through a microphone, goes around the streets of Gurugram sharing home remedies to fight the coronavirus. And while the remedies shared by the renowned Ayurvedic doctor are proven ways to boost immunity, he went a step too far by saying it will kill the virus. Dr Arora’s viral video gained the attention of thousands when a Facebook user posted a video of a selfless doctor spreading awareness on the pandemic. Arora was then given the name “Audi waale doctor”. According to <a href="https://www.facebook.com/ZeeNews/videos/254776185749531">reports</a>, Dr Arora is a renowned ayurvedic doctor with more than 20 years of experience. He is currently serving as a senior consultant at Sir Ganga Ram Hospital. Dr Arora is also seen in ads of <keyword id="62997" type="DOMAIN" weightage="20" keywordseo="Dabur">Dabur</keyword> Chyawanprash recommending it as an immunity booster. <div type="javascript" title="Custom" contenttype="Video"><cdata><![CDATA[]]></cdata></div> According to him, if you keep drinking lukewarm water slowly (just like you enjoy a hot cup of tea he said) but often, it kills the coronavirus. However, there is no proven scientific study behind it, and earlier, the Press Information Bureau (PIB) had also debunked this rumour that coronavirus can be treated with warm water. <div type="twitter" handle="PIBFactCheck" handlename="PIB Fact Check" image="http://pbs.twimg.com/profile_images/1214504395359916032/9Xk_-_ro_normal.jpg" favoritecount="1842" retweetcount="990" status="#Coronavirus CANNOT be treated by gargling with warm water mixed with salt and vinegar.This is #fakenews circulat… https://t.co/acRkIfcSNx" createdat="1584359141000" id="1239518193422446592"></div> The doctor then suggested that everyone should consume cloves, along with black pepper, ajwain (carom seeds) and hot water. While Ayurveda considers these as immunity boosters — they are not yet proven to be remedies for coronavirus. Ayurveda – the field of alternative medicine has gained immense popularity in the wake of COVID-19. The ancient practice of Ayurveda with <keyword id="3658" type="COUNTRY" weightage="20" keywordseo="India">India</keyword> as its land of origin can lead the fight against coronavirus, said a <a href="https://www.newsbreak.com/news/0OtB5GOp/ayurveda-silently-battling-covid-19">seasoned Clinical Assistant Professor </a>of Medicine from Weill Cornell Medical College in New York. In May, the central government also launched three Central AYUSH (The Ministry of Ayurveda, Yoga &amp; Naturopathy, Unani, Siddha and Homoeopathy) ministry-based studies related to COVID-19. However, so far the government hasn’t derived any remedy in Ayurveda for coronavirus. Acharya Balakrishna, the chairman of Patanjali, had earlier said that trials are going on to see the potential of Ayurveda in the cure of coronavirus. “The proposed treatment regime is designed to add efficacy and potency of Ayurvedic medicines in treating COVID-19 infection in combination with ICMR (Indian Council of Medical Research) approved Hydroxychloroquine. This regime is meticulously designed with clinical relevance for the ayurvedic intervention therapy on war footing to cope with COVID-19 infection.” <a href="https://www.freepressjournal.in/business/clinical-trials-for-ayurvedic-cure-of-covid-19-are-underway-says-patanjalis-acharya-balkrishna">he said in an interview.</a> There are several other <a href="https://indianexpress.com/article/cities/chandigarh/ayurveda-medicine-trial-to-begin-on-asymptomatic-covid-19-patients-in-chandigarh-6402458/">Ayurvedic medicine trials</a> currently taking place in India. SEE ALSO: <a href="https://www.businessinsider.in/science/health/news/coronavirus-myths-and-facts-here-are-some-rumours-about-covid-19-that-arent-true/articleshow/74487962.cms">Coronavirus myths and facts</a> <a href="https://www.businessinsider.in/india/news/data-of-coronavirus-patients-state-wise-in-india/articleshow/74669748.cms">Coronavirus cases in India state wise</a> <a href="https://www.businessinsider.in/topic/coronavirus">Coronavirus News and Updates</a>

A renowned doctor in Gurugram is recommending spices as cure for Covid-19 – take it with a pinch of salt

Tuesday, April 2: Exaggerated claims of unbelievable results with the use of consumer products are not new in the Indian advertisement industry. But, the law of the land does explicitly prohibit and punish misleading advertisements from time to time. One such case is grabbing headlines of late. <keyword id="20083249" type="General" weightage="20" keywordseo="baba-ramdev" source="keywords">Baba Ramdev</keyword> and <keyword id="20752072" type="General" weightage="20" keywordseo="acharya-balkrishna" source="keywords">Acharya Balkrishna</keyword>, co-founder and managing director of <keyword id="19980518" type="General" weightage="100" keywordseo="patanjali" source="keywords">Patanjali</keyword>, respectively, appeared before the <keyword id="19895345" type="General" weightage="20" keywordseo="supreme-court" source="keywords">Supreme Court</keyword> today for a hearing regarding a case involving misleading advertisements. So, what exactly happened? <cmsannotation type="cmsannotation" annotationid="A case of false and misleading advertisements" comment="subhead" text="A case of false and misleading advertisements">A case of false and misleading advertisements</cmsannotation> The case began in November last year when the Supreme Court, responding to a petition by the Indian Medical Association (IMA), cautioned <keyword id="6406649" type="General" weightage="20" keywordseo="patanjali-ayurved" source="Orion">Patanjali Ayurved</keyword> against airing "false" and "misleading" claims in its advertisements about medicinal products. The IMA cited several ads that allegedly portrayed allopathic medicine and doctors negatively, claiming that companies producing ayurvedic medicines made disparaging remarks to deceive the public. Despite the Supreme Court's cautionary stance and prohibition on advertising products claiming to treat specific ailments under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, Ramdev and Balkrishna reportedly conducted a press conference, once again making misleading claims about Patanjali's ability to cure various conditions permanently. Subsequently, on February 27, the Supreme Court expressed dissatisfaction with Patanjali's continuous dissemination of false advertisements regarding medicinal cures and issued notices to the company, questioning why contempt proceedings should not be initiated. It also chastised the government for not taking action and “sitting with their eyes shut”. On March 21, the Court summoned Baba Ramdev and Balkrishna to personally appear before it on April 2 to address their failure to respond to the contempt notice regarding misleading advertisements about medicinal cures. <cmsannotation type="cmsannotation" annotationid="What’s the latest update?" comment="subhead" text="What’s the latest update?">What’s the latest update?</cmsannotation> In today's hearing, the Supreme Court criticised Ramdev and Balkrishna for their "absolute defiance" in failing to submit proper affidavits of compliance and for disregarding legal directives. The Court also rebuked Patanjali's MD for describing the Drugs and Cosmetics (Magic Remedies) Act as "archaic". Noting that Patanjali's advertisements are in the "teeth of law" of the land, the Court warned Ramdev to prepare for potential consequences. Justices Hima Kohli and Ahsanuddin Amanullah, presiding over the bench, declined to acknowledge the apology extended by Patanjali last month. Subsequently, Ramdev's attorney, reportedly with folded hands, reiterated that both Ramdev and Balakrishna were extending a personal and unconditional apology before the court. Finally, the Court has granted Ramdev and Balkrishna a final opportunity to file affidavits in one week and mandated their presence at the next hearing on April 10.

Government ‘sitting with its eyes shut’, says Supreme Court as Patanjali’s misleading advertisement case drags on

<ul><li>Baba <keyword id="6369109" type="PERSON" weightage="20" keywordseo="ramdev">Ramdev</keyword>'s Patanjali Ayurved is considering to bid for the title sponsorship of the upcoming <keyword id="6354831" type="UNKNOWN" weightage="20" keywordseo="indian-premier-league">Indian Premier League</keyword> (IPL), according to a company official. </li><li>The slot of the title sponsorship of IPL was vacated after the Chinese handset maker Vivo decided to exit from it.</li><li>The move would help the Haridwar-based firm access a <keyword id="9731419" type="UNKNOWN" weightage="20" keywordseo="global-marketing-platform">global marketing platform</keyword>, as Patanjali is focusing on exports for its Ayurveda-based FMCG products.</li></ul>Baba Ramdev's Patanjali Ayurved is considering to bid for the title sponsorship of the upcoming Indian Premier League (IPL), according to a company official. The slot of the title sponsorship of IPL was vacated after the Chinese handset maker Vivo decided to exit from it. The move would help the Haridwar-based firm access a global marketing platform, as Patanjali is focusing on exports for its Ayurveda-based FMCG products. Confirming the development, Patanjali spokesperson S K Tijarawala told : "We are considering this". "This is for Vocal For Local and making one Indian brand as global, this is the right platform. We are considering into that perspective," he said. However, Tijarawala also added that the company is yet to take a final call on the issue. "We have to take a final decision, whether we would take it or not," Tijarawala added. According to him, the <keyword id="81008" type="ORGANIZATION" weightage="20" keywordseo="Board-of-Control-for-Cricket-in-India">Board of Control for Cricket in India</keyword> (BCCI) is coming with the expression of interest on Monday and it has to submit its proposal by August 14. Last week, BCCI and Vivo decided to suspend their partnership for the 2020 IPL beginning on September 19, in the UAE, amid clamour to boycott Chinese products in the wake of the Sino-India border stand-off. The title sponsorship is a significant part of the IPL's commercial revenue, half of which is shared equally by the franchises. Vivo won the IPL title sponsorship rights for five years from 2018 to 2022 for a reported sum of Rs 2,190 crore, approximately Rs 440 crore per annum. The Haridwar-based Patanjali group has an estimated turnover of around Rs 10,500 crores. It had acquired debt-ridden Ruchi Soya in a corporate insolvency resolution process for around Rs 4,350 crore after competing with <keyword id="6367820" type="COMPANY" weightage="20" keywordseo="adani-group">Adani Group</keyword>. Patanjali Ayurved had reported a revenue of Rs 8,329 crore in FY 2018-19. However overall the group's turnover was much higher as Patanjali Ayurved consists of mainly its FMCG business and its Ayurvedic medicines. SEE ALSO: <a href="https://www.businessinsider.in/india/news/these-are-the-tabletop-airports-in-india-two-of-them-have-seen-major-plane-crashes-in-last-10-years/articleshow/77427972.cms">These are the tabletop airports in India – two of them have seen major plane crashes in last 10 years</a> <a href="https://www.businessinsider.in/business/startups/news/how-karan-bajaj-sold-his-less-than-18-month-old-startup-white-hat-jr-to-byjus/articleshow/77415329.cms">A WhatsApp message, six weeks of talks and a $300 million deal – how Karan Bajaj sold his less than 18-month old startup White Hat Jr to Byju’s</a> <a href="https://www.businessinsider.in/business/news/mukesh-ambani-is-now-the-worlds-fourth-richest-person-after-he-beat-louis-vuitton-owner-bernard-arnault/articleshow/77431776.cms">Mukesh Ambani is now the world’s fourth-richest person after he beat Louis Vuitton owner Bernard Arnault</a>

Patanjali says it is considering to bid for the title sponsorship of the upcoming Indian Premier League

Expanding the scope of its hearing in the <keyword id="19980518" type="General" weightage="20" keywordseo="Patanjali" source="keywords">Patanjali</keyword> Ayurved case, the <keyword id="19895345" type="General" weightage="20" keywordseo="Supreme-Court" source="keywords" meta.keywordsubtype="org" meta.entityname="Supreme Court" meta.hostid="266" meta.entityid="Supreme Court">Supreme Court</keyword> on Tuesday took a stern view of <keyword id="20610549" type="General" weightage="20" keywordseo="misleading-advertisements" source="keywords">misleading advertisements</keyword> by FMCG firms and asked three Union ministries to inform it about the steps they have taken to curb the practice which takes "public for a ride" and adversely affects their health. The court passed the order after Yoga guru Ramdev and his aide Balkrishna of Patanjali Ayurved Ltd. told a bench of Justices Hima Kohli and Ahsanuddin Amanullah that they have issued unqualified public apology in as many as 67 newspapers over misleading advertisements and are willing to issue additional advertisements expressing their contrition. The bench said the public apology published in newspapers were not on record and asked those to be filed within two days. It posted the matter for April 30 for further consideration. While hearing the Patanjali case, the apex court said the implementation of the relevant provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, the Drugs and Cosmetics Act and the Consumer Protection Act and the related rules also needed a closer examination. It said the issue was not limited to Patanjali but extended to all Fast-Moving Consumer Goods (FMCG) firms which have been issuing "misleading advertisements and taking the public for a ride, in particular affecting the health of babies, school-going children and senior citizens who have been consuming products on the basis of the said misrepresentation". "We must clarify that we are not here to gun for a particular party or a particular agency or a particular authority. This is a PIL, and in the larger interest of the consumers, public should know which way they are going and how and why they can be misled, and how authorities are acting to prevent it," the bench said. The court asked the Union ministries of consumer affairs, information and broadcasting, and information technology to explain what action they have taken to prevent the misuse of consumer laws. It also sought an explanation from the Centre over an August 2023 letter issued by the Ministry of Ayush to the licencing authorities of all states and Union Territories and drug controllers of Ayush asking them to not initiate any action under rule 170 of Drugs and Cosmetics Rules, 1945. The bench also asked the <keyword id="20083252" type="General" weightage="20" keywordseo="Indian-Medical-Association" source="keywords" meta.keywordsubtype="org" meta.entityname="Indian Medical Association" meta.hostid="266" meta.entityid="Indian Medical Association">Indian Medical Association</keyword> (IMA), the petitioner in the Patanjali advertisements case, to "put its house in order". It said several complaints have been made about alleged unethical acts by members of the IMA who prescribe highly expensive medicines and line of treatment. The bench also ordered impleading the National Medical Commission (NMC) as a respondent in the matter for effective assistance to the court. At the outset, senior advocate Mukul Rohatgi, appearing for Ramdev and Patanjali Ayurved Ltd managing director Balkrishna, told the bench they have issued on Monday unqualified apology for the "lapses" on their part. "Where? Why it is not filed?" the bench asked. Rohatgi said it was issued on Monday in 67 newspapers across the country. When the court asked the senior advocate why did the respondents wait for a whole week before publishing the public apology, Rohatgi said, "Its language had to be changed". The court also quizzed him about the size of advertisements. "Is it the same size of advertisements that you normally issue in newspapers?" it asked Rohatgi, who submitted "It costs tens of lakhs (of rupees)". The bench ordered that the apology published be filed on record and added it wanted to see the actual advertisement published in newspapers. "The said advertisements are not on record. It is submitted that the same have been collated and shall be filed in the course of the day with copies to counsel for the parties. Needful shall be done within two days with copies to counsel for the parties," it said. The counsel said additional advertisement shall be issued by Ramdev and Balkrishna tendering unqualified apology for the lapses on their part. The bench said it was necessary to implead the three central ministries in order to examine the steps taken to prevent the abuse of the Drugs and Magic Remedies (Objectionable Advertisements) Act and rules, the Drugs and Cosmetics Act and the Consumer Protection Act. It said these ministries shall file affidavits enunciating the action they have taken to prevent the misuse/abuse of these statutes along with the relevant data since 2018. The bench said licencing authorities of all states and UTs shall also be impleaded as co-respondents in the matter. The bench told the IMA's counsel that while they are pointing fingers at Patanjali, "the other four fingers are also pointing at you (IMA)". On April 16, the apex court had warned Ramdev and Balkrishna against any attempt to "degrade allopathy" and permitted them to tender a "public apology and show contrition" within a week in the contempt proceedings in the misleading advertisements case against Patanjali Ayurved Ltd. The apex court is hearing a plea filed in 2022 by the IMA alleging a smear campaign against the Covid vaccination drive and modern systems of medicine. Ramdev and Balkrishna had earlier tendered an "unconditional and unqualified apology" before the top court over advertisements issued by the firm making tall claims about the medicinal efficacy of its products. SEE ALSO:<a href="https://www.businessinsider.in/tech/mobile/news/google-pixel-8a-may-be-more-expensive-than-its-predecessor-as-per-a-new-leak/articleshow/109499394.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/mobile/news/google-pixel-8a-may-be-more-expensive-than-its-predecessor-as-per-a-new-leak/articleshow/109499394.cms" target="_blank">Google Pixel 8a may be more expensive than its predecessor, as per a new leak</a><a href="https://www.businessinsider.in/tech/mobile/webstories/best-smartphones-under-25000-in-india/slidelist/109529634.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/mobile/webstories/best-smartphones-under-25000-in-india/slidelist/109529634.cms" target="_blank">Best smartphones under ₹25,000 in India</a><a href="https://www.businessinsider.in/sports/webstories/at-17-indian-chess-prodigy-d-gukesh-becomes-youngest-challenger-for-world-championship/slidelist/109492021.cms" target="_blank"></a> <a href="https://www.businessinsider.in/sports/webstories/at-17-indian-chess-prodigy-d-gukesh-becomes-youngest-challenger-for-world-championship/slidelist/109492021.cms" target="_blank">At 17, Indian chess prodigy D Gukesh becomes youngest challenger for World Championship</a>

You Searched For "patanjali covid 19 medicine" and got 8 results

Ramdev's Patanjali launched COVID-19 medicine, 100% recovery in 7 days

PTI

Ramdev's Patanjali claims to have COVID-19 medicine; Ayush Ministry frowns

PTI

Patanjali’s Acharya Balkrishna is the biggest loser on Hurun’s Rich List of Indian billionaires

Prabhjote Gill

Patanjali Ayurved posts Rs 3,562 cr revenue for Apr-Sep

PTI

A renowned doctor in Gurugram is recommending spices as cure for Covid-19 – take it with a pinch of salt

BI India Bureau

Government ‘sitting with its eyes shut’, says Supreme Court as Patanjali’s misleading advertisement case drags on

Kunal Kambli

Patanjali says it is considering to bid for the title sponsorship of the upcoming Indian Premier League

PTI

Supreme Court expands Patanjali misleading ads hearing to include FMCG companies

PTI

Popular Keywords

Buying Guides